Ypsomed Forecast, price target & analysts
Ypsomed Target price 2025 - Analyst rating & recommendation
Ypsomed Classifications & Recommendation:
Ypsomed Price Target
| Target Price | CHF419.75 |
| Price | CHF350.00 |
| Potential |
19.93%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Ypsomed 2026 .
The average Ypsomed target price is CHF419.75.
This is
19.93%
register free of charge
CHF446.00
27.43%
register free of charge
CHF400.00
14.29%
register free of charge
|
|
| A rating was issued by 5 analysts: 4 Analysts recommend Ypsomed to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Ypsomed stock has an average upside potential 2026 of
19.93%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Mar '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million CHF | 548.46 | 693.75 |
| 10.25% | 26.49% | |
| EBITDA Margin | 28.43% | 31.30% |
| 22.07% | 10.09% | |
| Net Margin | 14.26% | 14.28% |
| 36.29% | 0.11% |
4 Analysts have issued a sales forecast Ypsomed 2025 . The average Ypsomed sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Ypsomed EBITDA forecast 2025. The average Ypsomed EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Ypsomed Analysts have issued a net profit forecast 2025. The average Ypsomed net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Mar '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 5.74 | 7.27 |
| 50.26% | 26.66% | |
| P/E | 48.23 | |
| EV/Sales | 7.28 |
2 Analysts have issued a Ypsomed forecast for earnings per share. The average Ypsomed <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Ypsomed stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current Ypsomed Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| RESEARCH PARTNERS AG | Locked ➜ Locked | Locked | Dec 22 2024 |
| BNP PARIBAS EXANE | Locked ➜ Locked | Locked | Nov 24 2024 |
| ODDO BHF | Locked ➜ Locked | Locked | Nov 12 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
RESEARCH PARTNERS AG: Locked ➜ Locked
|
Dec 22 2024 |
|
Locked
BNP PARIBAS EXANE: Locked ➜ Locked
|
Nov 24 2024 |
|
Locked
ODDO BHF: Locked ➜ Locked
|
Nov 12 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
